AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Senores Pharma files SEBI Regulation 74(5) Certificate for Q3 FY26
Senores Pharmaceuticals Limited
January 12, 2026, 12:23 PM
Top Queries to Ask About Senores Pharmaceuticals Limited
InstantThinking to buy or sell Senores Pharmaceuticals Limited? Ask AI before you act.
Trusted by 5,000+ users
More Details on This News
Senores Pharmaceuticals Limited has submitted a certificate pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. This certificate was received from MUFG Intime India Private Limited (formerly Link Intime India Private Limited), the company's Registrar and Share Transfer Agent.
The certificate pertains to the quarter ended December 31, 2025. It confirms that the securities received from depository participants for dematerialization during the quarter were confirmed (accepted/rejected) and subsequently listed on the stock exchanges where the company's earlier securities are listed. MUFG Intime India also confirmed that the security certificates received for dematerialization were mutated and cancelled after due verification by the depository participant, with the names of the depositories substituted in the register of members within the prescribed timelines.
The company has requested that this information be taken on record.
More News on Senores Pharmaceuticals Limited
Analyze Senores Pharmaceuticals Limited